Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × cabozantinib × 30 days × Clear all

Status

Sponsor Class

Study Type

Interventional 43 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Surveys and Questionnaires 21 Blood Specimen Collection 20 Specimen Handling 12 Magnetic Resonance Spectroscopy 7 Drug Therapy 7 palbociclib 6 Observation 5 Data Collection 5 Bevacizumab 5 darolutamide 4 Interviews as Topic 4 Biopsy 4 ribociclib 3 osimertinib 3 atezolizumab 3 Surgical Procedures, Operative 3 Restraint, Physical 3 Radiotherapy 3 Mastectomy, Segmental 3 Breath Tests 3 trastuzumab deruxtecan 2 ravulizumab 2 lutetium Lu 177 dotatate 2 larotrectinib 2 glofitamab 2 gallium Ga 68 dotatate 2 fluorodopa F 18 2 enzalutamide 2 apalutamide 2 Ultrasonography 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04416646 2026-04-13

ZEBRA

Istituto Oncologico Veneto IRCCS

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡